Literature DB >> 1611819

Structural and biologic properties of integrin-mediated cell adhesion.

D A Cheresh1.   

Abstract

The integrins are a family of proteins that mediate cellular adhesion mechanisms involved in development, differentiation, wound healing, immune recognition, and inflammation. In addition, these adhesion receptors also potentiate disease states including cancer, thrombosis, and inflammatory diseases. To understand the role of integrins in these processes, it is important to define their structural and functional properties. It is also imperative to understand the distribution of integrins on normal and malignant cell types. Integrins are regulated on the cell surface, and these events likely promote specific cellular adhesion mechanisms. This is of particular concern among tumor cells, which not only attach to the extracellular matrix but must invade and migrate through it. Integrins are surface-expressed proteins that mediate a linkage to the cytoskeleton within the cell, and thus cell morphology and traction during migration. Thus, by understanding the structural basis of integrin--ligand and integrin--cytoskeleton interactions we will gain insight into the molecular basis of cancer, thrombosis, wound healing, and inflammation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1611819

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  11 in total

1.  Extracellular matrix and integrin composition of the normal bladder wall.

Authors:  C B Wilson; J Leopard; D A Cheresh; R M Nakamura
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

2.  The efficacy evaluation of cryosurgery in pancreatic cancer patients with the expression of CD44v6, integrin-β1, CA199, and CEA.

Authors:  Gang Zhou; David Chiu; Dajiang Qin; Lizhi Niu; Jinlei Cai; Lihua He; Wenhao Huang; Kecheng Xu
Journal:  Mol Biotechnol       Date:  2012-09       Impact factor: 2.695

3.  Protein kinase A regulates Lewis lung carcinoma adherence to extracellular matrix components and spontaneous metastasis.

Authors:  G D Maier; K Vellody; J Meisinger; A Djordjevic; Y Lozano; M R Young
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

4.  Protein disulfide isomerase capture during thrombus formation in vivo depends on the presence of β3 integrins.

Authors:  Jaehyung Cho; Daniel R Kennedy; Lin Lin; Mingdong Huang; Glenn Merrill-Skoloff; Barbara C Furie; Bruce Furie
Journal:  Blood       Date:  2012-05-31       Impact factor: 22.113

5.  Inhibition of the alpha-nu integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo.

Authors:  M A Buerkle; S A Pahernik; A Sutter; A Jonczyk; K Messmer; M Dellian
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

6.  A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice.

Authors:  Steve Swenson; Radu O Minea; Cao Duc Tuan; Thu-Zan Thein; Thomas C Chen; Francis S Markland
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

7.  Alterations in integrin expression modulates invasion of pancreatic cancer cells.

Authors:  Naomi Walsh; Martin Clynes; John Crown; Norma O'Donovan
Journal:  J Exp Clin Cancer Res       Date:  2009-10-13

8.  Single subunit chimeric integrins as mimics and inhibitors of endogenous integrin functions in receptor localization, cell spreading and migration, and matrix assembly.

Authors:  S E LaFlamme; L A Thomas; S S Yamada; K M Yamada
Journal:  J Cell Biol       Date:  1994-09       Impact factor: 10.539

9.  Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3.

Authors:  A M Montgomery; J C Becker; C H Siu; V P Lemmon; D A Cheresh; J D Pancook; X Zhao; R A Reisfeld
Journal:  J Cell Biol       Date:  1996-02       Impact factor: 10.539

10.  Endothelial cells microparticle-associated protein disulfide isomerase promotes platelet activation in metabolic syndrome.

Authors:  Guan-Qi Fan; Ran-Ran Qin; Yi-Hui Li; Dai-Jun Song; Tong-Shuai Chen; Wei Zhang; Ming Zhong; Yun Zhang; Yan-Qiu Xing; Zhi-Hao Wang
Journal:  Oncotarget       Date:  2016-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.